Sanara MedTech Q1 2022 Earnings Report

Sanara MedTech reported record revenue in Q1 2022.

Key Takeaways

Sanara MedTech announced its Q1 2022 results, highlighting record revenue and the completion of the Precision Healing acquisition.

Generated record revenue in Q1 2022.

Achieved first month with sales over $3 million.

Completed acquisition of Precision Healing.

Focused on preparing 510(k)s for submission for the Precision Healing imager and assay.

Total Revenue

$7.81M

Previous year: $5.01M

+55.9%

EPS

-$0.41

Previous year: -$0.17

+141.2%

Gross Profit

$7.01M

Previous year: $4.54M

+54.5%

Cash and Equivalents

$16.1M

Previous year: $27.3M

-40.9%

Free Cash Flow

-$2.16M

Previous year: -$1.27M

+70.4%

Total Assets

$33.9M

Previous year: $39M

-13.0%

No specific forward guidance was provided in the press release.

Full financial data and analysis